25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

MAP (Microba) Stock Analysis
Buy, Hold or Sell?

Let's analyze Microba together

I guess you are interested in Microba Life Sciences Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • ๐Ÿ“Š Fundamental Analysis (FA) โ€“ Microbaโ€™s Financial Insights
  • ๐Ÿ“ˆ Technical Analysis (TA) โ€“ Microbaโ€™s Price Targets

I'm going to help you getting a better view of Microba Life Sciences Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Microba Life Sciences Ltd

I send you an email if I find something interesting about Microba Life Sciences Ltd.

1. Quick Overview

1.1. Quick analysis of Microba (30 sec.)










1.2. What can you expect buying and holding a share of Microba? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.08
Expected worth in 1 year
A$0.05
How sure are you?
33.3%

+ What do you gain per year?

Total Gains per Share
A$-0.03
Return On Investment
-20.2%

For what price can you sell your share?

Current Price per Share
A$0.15
Expected price per share
A$0.14 - A$0.3
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Microba (5 min.)




Live pricePrice per Share (EOD)
A$0.15
Intrinsic Value Per Share
A$-0.10 - A$-0.10
Total Value Per Share
A$-0.02 - A$-0.02

2.2. Growth of Microba (5 min.)




Is Microba growing?

Current yearPrevious yearGrowGrow %
How rich?$22.9m$28.2m-$3.5m-14.2%

How much money is Microba making?

Current yearPrevious yearGrowGrow %
Making money-$2.9m-$4.4m$1.4m50.6%
Net Profit Margin-83.4%-282.6%--

How much money comes from the company's main activities?

2.3. Financial Health of Microba (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Microba?

Welcome investor! Microba's management wants to use your money to grow the business. In return you get a share of Microba.

First you should know what it really means to hold a share of Microba. And how you can make/lose money.

Speculation

The Price per Share of Microba is A$0.15. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Microba.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Microba, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.08. Based on the TTM, the Book Value Change Per Share is A$-0.01 per quarter. Based on the YOY, the Book Value Change Per Share is A$0.00 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Microba.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps0.00-2.7%-0.01-4.4%-0.01-5.8%-0.01-4.5%-0.01-4.1%-0.01-4.1%
Usd Book Value Change Per Share0.000.0%0.00-3.2%0.000.9%0.002.0%0.001.9%0.001.9%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.000.0%0.00-3.2%0.000.9%0.002.0%0.001.9%0.001.9%
Usd Price Per Share0.13-0.12-0.19-0.14-0.09-0.09-
Price to Earnings Ratio-7.61--5.63--7.43--6.38--4.25--4.25-
Price-to-Total Gains Ratio-13.35--7,464,202.78--3,198,812.67--3,198,812.67--3,198,812.67-
Price to Book Ratio2.45-2.20-3.13-2.42-1.61-1.61-
Price-to-Total Gains Ratio-13.35--7,464,202.78--3,198,812.67--3,198,812.67--3,198,812.67-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.09639
Number of shares10374
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (10374 shares)-50.4629.51
Gains per Year (10374 shares)-201.85118.05
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-202-2120118108
20-404-4140236226
30-606-6160354344
40-807-8180472462
50-1009-10200590580
60-1211-12220708698
70-1413-14240826816
80-1615-16260944934
90-1817-1828010621052
100-2019-2030011801170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.018.00.00.0%0.018.00.00.0%0.018.00.00.0%
Book Value Change Per Share0.02.02.00.0%4.04.04.033.3%6.05.07.033.3%6.05.07.033.3%6.05.07.033.3%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.018.00.0%0.00.018.00.0%0.00.018.00.0%
Total Gains per Share0.02.02.00.0%4.04.04.033.3%6.05.07.033.3%6.05.07.033.3%6.05.07.033.3%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Microba Life Sciences Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share----0.0080%0.002-100%0.005-100%0.004-100%0.004-100%
Book Value Per Share--0.0800.086-7%0.098-19%0.091-12%0.067+19%0.067+19%
Current Ratio--2.1662.387-9%4.290-50%4.763-55%4.019-46%4.019-46%
Debt To Asset Ratio--0.2970.294+1%0.212+40%0.214+39%0.202+47%0.202+47%
Debt To Equity Ratio--0.4230.416+2%0.271+56%0.281+50%0.273+55%0.273+55%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--89688019.00087234371.500+3%151425295.500-41%124546370.364-28%124546370.364-28%124546370.364-28%
Eps---0.006-0.010+60%-0.014+111%-0.011+64%-0.010+49%-0.010+49%
Ev To Ebitda Ratio---4.705-4.130-12%-5.813+24%-5.687+21%-5.687+21%-5.687+21%
Ev To Sales Ratio--5.5474.635+20%18.381-70%13.821-60%13.821-60%13.821-60%
Free Cash Flow Per Share---0.003-0.007+113%-0.019+486%-0.012+284%-0.010+224%-0.010+224%
Free Cash Flow To Equity Per Share---0.003-0.007+140%-0.003+14%0.005-151%0.004-166%0.004-166%
Gross Profit Margin--1.0481.038+1%1.032+2%1.038+1%1.039+1%1.039+1%
Intrinsic Value_10Y_max---0.103----------
Intrinsic Value_10Y_min---0.103----------
Intrinsic Value_1Y_max---0.043----------
Intrinsic Value_1Y_min---0.043----------
Intrinsic Value_3Y_max---0.105----------
Intrinsic Value_3Y_min---0.101----------
Intrinsic Value_5Y_max---0.137----------
Intrinsic Value_5Y_min---0.129----------
Market Cap67177800.000-30%87331140.00083972250.000+4%133795785.000-35%99180557.500-12%66120371.667+32%66120371.667+32%
Net Profit Margin---0.710-0.834+17%-2.826+298%-2.024+185%-2.088+194%-2.088+194%
Operating Margin---1.361-1.247-8%-3.363+147%-2.573+89%-2.568+89%-2.568+89%
Operating Ratio--2.0212.072-2%4.534-55%3.578-44%3.567-43%3.567-43%
Pb Ratio1.882-30%2.4472.197+11%3.129-22%2.419+1%1.613+52%1.613+52%
Pe Ratio-5.850+23%-7.605-5.626-26%-7.430-2%-6.379-16%-4.253-44%-4.253-44%
Price Per Share0.150-30%0.1950.188+4%0.299-35%0.221-12%0.148+32%0.148+32%
Price To Free Cash Flow Ratio-11.793+23%-15.331-10.357-32%-5.232-66%-6.768-56%-4.512-71%-4.512-71%
Quick Ratio--1.7701.935-9%3.606-51%4.304-59%3.600-51%3.600-51%
Return On Assets---0.057-0.083+47%-0.122+116%-0.099+76%-0.121+115%-0.121+115%
Return On Equity---0.080-0.117+46%-0.156+93%-0.127+58%-0.186+131%-0.186+131%
Total Gains Per Share----0.0080%0.002-100%0.005-100%0.004-100%0.004-100%
Usd Book Value--22932784.28724709093.586-7%28217223.701-19%26096612.321-12%19219060.121+19%19219060.121+19%
Usd Book Value Change Per Share----0.0050%0.001-100%0.003-100%0.003-100%0.003-100%
Usd Book Value Per Share--0.0510.055-7%0.063-19%0.058-12%0.043+19%0.043+19%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--57633521.00956056807.126+3%97305894.888-41%80033497.596-28%80033497.596-28%80033497.596-28%
Usd Eps---0.004-0.007+60%-0.009+111%-0.007+64%-0.006+49%-0.006+49%
Usd Free Cash Flow---915130.516-1952517.127+113%-5366056.843+486%-3518091.325+284%-2968694.154+224%-2968694.154+224%
Usd Free Cash Flow Per Share---0.002-0.004+113%-0.012+486%-0.008+284%-0.007+224%-0.007+224%
Usd Free Cash Flow To Equity Per Share---0.002-0.004+140%-0.002+14%0.004-151%0.003-166%0.003-166%
Usd Market Cap43168454.280-30%56118990.56453960567.850+4%85977171.441-35%63733426.250-12%42488950.833+32%42488950.833+32%
Usd Price Per Share0.096-30%0.1250.120+4%0.192-35%0.142-12%0.095+32%0.095+32%
Usd Profit---1844803.712-2958714.344+60%-4455435.773+142%-3364529.578+82%-2968847.843+61%-2968847.843+61%
Usd Revenue--2597432.8973423441.218-24%1576336.356+65%2039407.785+27%1677223.628+55%1677223.628+55%
Usd Total Gains Per Share----0.0050%0.001-100%0.003-100%0.003-100%0.003-100%
 EOD+2 -5MRQTTM+21 -12YOY+20 -173Y+17 -205Y+22 -1510Y+22 -15

3.3 Fundamental Score

Let's check the fundamental score of Microba Life Sciences Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.850
Price to Book Ratio (EOD)Between0-11.882
Net Profit Margin (MRQ)Greater than0-0.710
Operating Margin (MRQ)Greater than0-1.361
Quick Ratio (MRQ)Greater than11.770
Current Ratio (MRQ)Greater than12.166
Debt to Asset Ratio (MRQ)Less than10.297
Debt to Equity Ratio (MRQ)Less than10.423
Return on Equity (MRQ)Greater than0.15-0.080
Return on Assets (MRQ)Greater than0.05-0.057
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Microba Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.599
Ma 20Greater thanMa 500.172
Ma 50Greater thanMa 1000.184
Ma 100Greater thanMa 2000.217
OpenGreater thanClose0.155
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Microba Life Sciences Ltd

Microba Life Sciences Limited provides microbiome testing, supplements, and analysis services in Australia, Europe, New Zealand, the United Arab Emirates, the United Kingdom, the United States, Asia, and Ireland. It operates through two segments, Testing Services and Supplements, and Research and Development. The company also develops pathology, therapeutics, and diagnostics services based on the human gut microbiome. In addition, it offers MetaPanel, a metagenomic test for pathogen detection; MetaXplore, a diagnostics under the brand Co-Biome and MetaXplore; non-diagnostic personal and research testing services; and data-driven therapeutics platform that develops therapies for ulcerative colitis, inflammatory bowel disease, and autoimmune diseases, as well as microbiome databank. Microba Life Sciences Limited was incorporated in 2017 and is based in Brisbane, Australia.

Fundamental data was last updated by Penke on 2025-05-13 05:48:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitย Microba earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareย Microba to theย Diagnostics & Research industry mean.
  • A Net Profit Margin of -71.0%ย means thatย $-0.71 for each $1ย in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Microba Life Sciences Ltd:

  • The MRQ is -71.0%. The company is making a huge loss. -2
  • The TTM is -83.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-71.0%TTM-83.4%+12.4%
TTM-83.4%YOY-282.6%+199.2%
TTM-83.4%5Y-208.8%+125.4%
5Y-208.8%10Y-208.8%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-71.0%-8.6%-62.4%
TTM-83.4%-8.8%-74.6%
YOY-282.6%0.5%-283.1%
3Y-202.4%-13.9%-188.5%
5Y-208.8%-5.0%-203.8%
10Y-208.8%-1.4%-207.4%
4.3.1.2. Return on Assets

Shows howย efficientย Microba is using its assets to generate profit.

  • Above 5% is considered healthyย but always compareย Microba to theย Diagnostics & Research industry mean.
  • -5.7% Return on Assets means thatย Microba generatedย $-0.06 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Microba Life Sciences Ltd:

  • The MRQ is -5.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-5.7%TTM-8.3%+2.6%
TTM-8.3%YOY-12.2%+3.9%
TTM-8.3%5Y-12.1%+3.8%
5Y-12.1%10Y-12.1%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-5.7%-2.0%-3.7%
TTM-8.3%-1.9%-6.4%
YOY-12.2%-0.6%-11.6%
3Y-9.9%-1.3%-8.6%
5Y-12.1%--12.1%
10Y-12.1%-0.1%-12.0%
4.3.1.3. Return on Equity

Shows how efficient Microba is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareย Microba to theย Diagnostics & Research industry mean.
  • -8.0% Return on Equity means Microba generated $-0.08ย for eachย $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Microba Life Sciences Ltd:

  • The MRQ is -8.0%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -11.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-8.0%TTM-11.7%+3.7%
TTM-11.7%YOY-15.6%+3.8%
TTM-11.7%5Y-18.6%+6.9%
5Y-18.6%10Y-18.6%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-8.0%-1.3%-6.7%
TTM-11.7%-1.0%-10.7%
YOY-15.6%0.2%-15.8%
3Y-12.7%-0.9%-11.8%
5Y-18.6%-1.1%-17.5%
10Y-18.6%-1.2%-17.4%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Microba Life Sciences Ltd.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measuresย how efficient Microba is operatingย .

  • Measures how much profit Microba makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareย Microba to theย Diagnostics & Research industry mean.
  • An Operating Margin of -136.1%ย means the company generated $-1.36 ย for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Microba Life Sciences Ltd:

  • The MRQ is -136.1%. The company is operating very inefficient. -2
  • The TTM is -124.7%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-136.1%TTM-124.7%-11.4%
TTM-124.7%YOY-336.3%+211.6%
TTM-124.7%5Y-256.8%+132.1%
5Y-256.8%10Y-256.8%0.0%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-136.1%-14.3%-121.8%
TTM-124.7%-23.7%-101.0%
YOY-336.3%-8.6%-327.7%
3Y-257.3%-0.5%-256.8%
5Y-256.8%3.4%-260.2%
10Y-256.8%2.9%-259.7%
4.3.2.2. Operating Ratio

Measures how efficient Microba is keepingย operating costsย low.

  • Below 1 is considered healthy (always compare toย Diagnostics & Research industry mean).
  • An Operation Ratio of 2.02 means that the operating costs are $2.02 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Microba Life Sciences Ltd:

  • The MRQ is 2.021. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.072. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.021TTM2.072-0.051
TTM2.072YOY4.534-2.462
TTM2.0725Y3.567-1.495
5Y3.56710Y3.5670.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.0211.325+0.696
TTM2.0721.284+0.788
YOY4.5341.301+3.233
3Y3.5781.294+2.284
5Y3.5671.320+2.247
10Y3.5671.201+2.366
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Microba Life Sciences Ltd.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Microba is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toย Diagnostics & Research industry mean).
  • A Current Ratio of 2.17ย means the company has $2.17 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Microba Life Sciences Ltd:

  • The MRQ is 2.166. The company is able to pay all its short-term debts. +1
  • The TTM is 2.387. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ2.166TTM2.387-0.221
TTM2.387YOY4.290-1.903
TTM2.3875Y4.019-1.632
5Y4.01910Y4.0190.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ2.1662.204-0.038
TTM2.3872.291+0.096
YOY4.2902.489+1.801
3Y4.7632.510+2.253
5Y4.0192.761+1.258
10Y4.0193.194+0.825
4.4.3.2. Quick Ratio

Measures if Microba is able to pay off Short-term Debt but only usingย theย most liquid assets.

  • Above 1 is considered healthy butย always compareย Microba to theย Diagnostics & Research industry mean.
  • A Quick Ratio of 1.77ย means the company can pay off $1.77 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Microba Life Sciences Ltd:

  • The MRQ is 1.770. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.935. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.770TTM1.935-0.165
TTM1.935YOY3.606-1.672
TTM1.9355Y3.600-1.665
5Y3.60010Y3.6000.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.7701.183+0.587
TTM1.9351.249+0.686
YOY3.6061.423+2.183
3Y4.3041.859+2.445
5Y3.6001.980+1.620
10Y3.6002.352+1.248
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Microba Life Sciences Ltd.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %ย of Microbaย assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareย Microba to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.30ย means that Microba assets areย financed with 29.7% credit (debt) and the remaining percentage (100% - 29.7%)ย is financed by its owners/shareholders.ย 

Let's take a look of the Debt to Asset Ratio trends of Microba Life Sciences Ltd:

  • The MRQ is 0.297. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.294. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.297TTM0.294+0.004
TTM0.294YOY0.212+0.082
TTM0.2945Y0.202+0.091
5Y0.20210Y0.2020.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2970.425-0.128
TTM0.2940.439-0.145
YOY0.2120.377-0.165
3Y0.2140.388-0.174
5Y0.2020.416-0.214
10Y0.2020.445-0.243
4.5.4.2. Debt to Equity Ratio

Measures ifย Microba is able toย pay off its debts by usingย shareholders equity.

  • Below 2 is considered healthy butย always compareย Microba to theย Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 42.3% means that company has $0.42 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Microba Life Sciences Ltd:

  • The MRQ is 0.423. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.416. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.423TTM0.416+0.007
TTM0.416YOY0.271+0.145
TTM0.4165Y0.273+0.143
5Y0.27310Y0.2730.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4230.571-0.148
TTM0.4160.571-0.155
YOY0.2710.554-0.283
3Y0.2810.690-0.409
5Y0.2730.673-0.400
10Y0.2730.641-0.368
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measuresย how much money you payย for each share forย every $1 in earnings Microba generates.

  • Above 15 is considered overpriced butย always compareย Microba to theย Diagnostics & Research industry mean.
  • A PE ratio of -7.61 means the investor is paying $-7.61ย for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Microba Life Sciences Ltd:

  • The EOD is -5.850. Based on the earnings, the company is expensive. -2
  • The MRQ is -7.605. Based on the earnings, the company is expensive. -2
  • The TTM is -5.626. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.850MRQ-7.605+1.755
MRQ-7.605TTM-5.626-1.979
TTM-5.626YOY-7.430+1.804
TTM-5.6265Y-4.253-1.373
5Y-4.25310Y-4.2530.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-5.850-0.413-5.437
MRQ-7.605-0.716-6.889
TTM-5.626-0.661-4.965
YOY-7.4300.255-7.685
3Y-6.3790.171-6.550
5Y-4.2533.686-7.939
10Y-4.2538.057-12.310
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Microba Life Sciences Ltd:

  • The EOD is -11.793. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -15.331. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.357. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.793MRQ-15.331+3.538
MRQ-15.331TTM-10.357-4.974
TTM-10.357YOY-5.232-5.125
TTM-10.3575Y-4.512-5.845
5Y-4.51210Y-4.5120.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-11.793-0.465-11.328
MRQ-15.331-0.915-14.416
TTM-10.357-0.457-9.900
YOY-5.232-1.305-3.927
3Y-6.768-0.468-6.300
5Y-4.512-0.816-3.696
10Y-4.512-1.980-2.532
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofย Microba is to cheap or to expensiveย compared to its book value.

  • At or below 1 is considered healthyย (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 2.45 means the investor is paying $2.45ย for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Microba Life Sciences Ltd:

  • The EOD is 1.882. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.447. Based on the equity, the company is underpriced. +1
  • The TTM is 2.197. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.882MRQ2.447-0.565
MRQ2.447TTM2.197+0.250
TTM2.197YOY3.129-0.932
TTM2.1975Y1.613+0.585
5Y1.61310Y1.6130.000
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD1.8821.875+0.007
MRQ2.4472.105+0.342
TTM2.1971.998+0.199
YOY3.1292.269+0.860
3Y2.4192.471-0.052
5Y1.6133.285-1.672
10Y1.6134.116-2.503
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-12-31. Currency in AUD. All numbers in thousands.

Summary
Total Assets50,785
Total Liabilities15,098
Total Stockholder Equity35,687
 As reported
Total Liabilities 15,098
Total Stockholder Equity+ 35,687
Total Assets = 50,785

Assets

Total Assets50,785
Total Current Assets22,450
Long-term Assets28,336
Total Current Assets
Cash And Cash Equivalents 17,316
Short-term Investments 139
Net Receivables 758
Inventory 2,140
Other Current Assets 2,097
Total Current Assets  (as reported)22,450
Total Current Assets  (calculated)22,450
+/-0
Long-term Assets
Property Plant Equipment 4,620
Goodwill 9,710
Intangible Assets 9,226
Long-term Assets Other 4,779
Long-term Assets  (as reported)28,336
Long-term Assets  (calculated)28,336
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,366
Long-term Liabilities4,732
Total Stockholder Equity35,687
Total Current Liabilities
Short-term Debt 1,532
Other Current Liabilities 8,834
Total Current Liabilities  (as reported)10,366
Total Current Liabilities  (calculated)10,366
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)4,732
Long-term Liabilities  (calculated)0
+/- 4,732
Total Stockholder Equity
Common Stock102,882
Retained Earnings -69,563
Accumulated Other Comprehensive Income 2,369
Other Stockholders Equity 0
Total Stockholder Equity (as reported)35,687
Total Stockholder Equity (calculated)35,687
+/-0
Other
Cash and Short Term Investments 17,455
Common Stock Shares Outstanding 447,852
Liabilities and Stockholders Equity 50,785
Net Debt -13,846
Net Working Capital 12,083
Short Long Term Debt Total 3,470



6.2. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
0
18,488
18,488
16,163
16,163
39,479
39,479
51,641
51,641
46,953
46,953
65,236
65,236
58,040
58,040
50,785
50,785
50,78550,78558,04058,04065,23665,23646,95346,95351,64151,64139,47939,47916,16316,16318,48818,48800
   > Total Current Assets 
6,897
0
16,220
16,220
13,208
13,208
35,817
35,817
46,892
46,892
41,525
41,525
42,519
42,519
32,250
32,250
22,450
22,450
22,45022,45032,25032,25042,51942,51941,52541,52546,89246,89235,81735,81713,20813,20816,22016,22006,897
       Cash And Cash Equivalents 
-6,897
0
12,979
13,029
10,133
10,133
30,581
30,785
41,954
41,954
32,044
18,682
27,846
27,846
20,889
20,889
17,316
17,316
17,31617,31620,88920,88927,84627,84618,68232,04441,95441,95430,78530,58110,13310,13313,02912,9790-6,897
       Short-term Investments 
13,795
0
50
50
0
0
204
204
0
0
204
0
204
204
204
0
139
139
1391390204204204020400204204005050013,795
       Net Receivables 
0
0
376
1,650
416
2,057
7,236
3,423
319
3,358
725
7,236
1,076
11,270
1,636
8,103
758
758
7587588,1031,63611,2701,0767,2367253,3583193,4237,2362,0574161,65037600
       Other Current Assets 
0
0
2,302
2,057
2,224
583
1,601
1,249
4,057
1,018
7,908
1,142
11,336
1,347
7,276
1,014
2,097
2,097
2,0972,0971,0147,2761,34711,3361,1427,9081,0184,0571,2491,6015832,2242,0572,30200
   > Long-term Assets 
-6,897
0
2,267
2,267
2,955
2,955
3,662
3,662
4,749
4,749
5,428
5,428
22,717
22,717
25,790
25,790
28,336
28,336
28,33628,33625,79025,79022,71722,7175,4285,4284,7494,7493,6623,6622,9552,9552,2672,2670-6,897
       Property Plant Equipment 
0
0
1,196
1,196
1,792
1,792
2,808
2,808
2,831
2,831
2,581
2,581
2,990
2,990
3,911
3,911
4,620
4,620
4,6204,6203,9113,9112,9902,9902,5812,5812,8312,8312,8082,8081,7921,7921,1961,19600
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,450
8,450
9,710
9,710
9,7109,7108,4508,45000000000000000
       Intangible Assets 
0
0
246
246
223
1,918
854
2,847
202
202
186
2,847
15,875
15,875
8,974
13,430
9,226
9,226
9,2269,22613,4308,97415,87515,8752,8471862022022,8478541,91822324624600
       Long-term Assets Other 
-6,897
0
825
825
734
-960
644
-1,993
1,716
1,716
2,661
0
3,851
3,851
4,455
21,880
4,779
4,779
4,7794,77921,8804,4553,8513,85102,6611,7161,716-1,993644-9607348258250-6,897
> Total Liabilities 
0
0
3,552
3,464
5,634
5,634
5,943
5,848
6,284
6,284
8,379
8,379
15,988
15,988
16,824
16,824
15,098
15,098
15,09815,09816,82416,82415,98815,9888,3798,3796,2846,2845,8485,9435,6345,6343,4643,55200
   > Total Current Liabilities 
0
0
3,354
3,354
4,795
4,795
5,264
5,264
5,569
5,569
7,824
7,824
12,990
12,990
12,367
12,367
10,366
10,366
10,36610,36612,36712,36712,99012,9907,8247,8245,5695,5695,2645,2644,7954,7953,3543,35400
       Short-term Debt 
0
0
109
-154
38
404
902
841
128
722
359
0
118
868
1,208
1,208
1,532
1,532
1,5321,5321,2081,208868118035972212884190240438-15410900
       Short Long Term Debt 
0
0
0
0
0
0
0
364
0
0
0
359
0
0
0
395
0
0
003950003590003640000000
       Accounts payable 
0
0
354
354
1,411
1,411
2,982
813
0
2,798
2,982
2,982
0
7,206
3,697
3,697
0
0
003,6973,6977,20602,9822,9822,79808132,9821,4111,41135435400
       Other Current Liabilities 
0
0
2,891
2,041
3,346
2,021
3,936
2,730
5,441
546
4,484
2,224
12,872
2,734
7,461
5,273
8,834
8,834
8,8348,8345,2737,4612,73412,8722,2244,4845465,4412,7303,9362,0213,3462,0412,89100
   > Long-term Liabilities 
0
0
198
110
839
839
679
583
715
715
555
555
2,998
2,998
4,457
4,457
4,732
4,732
4,7324,7324,4574,4572,9982,99855555571571558367983983911019800
       Long term Debt Total 
0
0
0
0
0
670
0
484
0
465
0
234
0
0
0
0
0
0
00000023404650484067000000
       Other Liabilities 
0
0
0
0
0
0
0
0
250
250
321
321
0
0
0
0
0
0
00000032132125025000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
1,716
1,716
2,661
2,661
0
0
0
0
0
0
0000002,6612,6611,7161,71600000000
> Total Stockholder Equity
7,704
0
14,936
14,936
10,529
10,529
33,536
33,536
45,356
45,356
38,574
38,574
49,248
49,248
41,216
41,216
35,687
35,687
35,68735,68741,21641,21649,24849,24838,57438,57445,35645,35633,53633,53610,52910,52914,93614,93607,704
   Common Stock
0
0
33,483
33,483
34,789
34,789
62,884
62,884
80,122
80,122
80,374
80,374
102,811
102,811
102,882
102,882
102,882
102,882
102,882102,882102,882102,882102,811102,81180,37480,37480,12280,12262,88462,88434,78934,78933,48333,48300
   Retained Earnings Total Equity000000000000000000
   Accumulated Other Comprehensive Income 
7,704
0
1,185
1,185
1,502
1,502
1,855
1,855
2,116
2,116
2,083
0
1,808
1,808
2,156
2,156
2,369
2,369
2,3692,3692,1562,1561,8081,80802,0832,1162,1161,8551,8551,5021,5021,1851,18507,704
   Capital Surplus 000000000000000000
   Treasury Stock000000000000000000
   Other Stockholders Equity 
0
0
1,185
0
1,502
-9
1,855
0
2,116
2,116
0
2,083
0
0
0
0
0
0
0000002,08302,1162,11601,855-91,50201,18500



6.3. Balance Sheets

Currency in AUD. All numbers in thousands.




6.4. Cash Flows

Currency in AUD. All numbers in thousands.




6.5. Income Statements

Currency in AUD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue12,090
Cost of Revenue-6,185
Gross Profit5,9055,905
 
Operating Income (+$)
Gross Profit5,905
Operating Expense-32,748
Operating Income-26,843-26,843
 
Operating Expense (+$)
Research Development10,836
Selling General Administrative12,179
Selling And Marketing Expenses786
Operating Expense32,74823,801
 
Net Interest Income (+$)
Interest Income1,005
Interest Expense-69
Other Finance Cost-0
Net Interest Income936
 
Pretax Income (+$)
Operating Income-26,843
Net Interest Income936
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-19,990-33,696
EBIT - interestExpense = -20,040
-19,990
-19,869
Interest Expense69
Earnings Before Interest and Taxes (EBIT)-19,971-19,921
Earnings Before Interest and Taxes (EBITDA)-17,101
 
After tax Income (+$)
Income Before Tax-19,990
Tax Provision--51
Net Income From Continuing Ops-19,938-19,938
Net Income-19,938
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses32,786
Total Other Income/Expenses Net6,853-936
 

Technical Analysis of Microba
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Microba. The general trend of Microba is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Microba's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Microba Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Supportย is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistanceย is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Microba Life Sciences Ltd.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.23 < 0.24 < 0.3.

The bearish price targets are: 0.14.

Know someone who trades $MAP? Share this with them.๐Ÿ‘‡

Microba Life Sciences Ltd Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theย moving averageย of the selected period.

  • Moving averages are laggingย trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Microba Life Sciences Ltd. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Microba Life Sciences Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theย momentumย of theย selected period based on two moving averages.

  • MACD is aย lagging momentumย indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Microba Life Sciences Ltd. The current macd is -0.00999896.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Microba price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Microba. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Microba price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Microba Life Sciences Ltd Daily Moving Average Convergence/Divergence (MACD) ChartMicroba Life Sciences Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Microba Life Sciences Ltd. The current adx is 24.27.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Microba shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Microba Life Sciences Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Showsย the current trend.
  • Showsย potential entry signals.
  • Showsย ย potential exit signals.
  • Can be used to placeย trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Microba Life Sciences Ltd. The current sar is 0.18579395.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Microba Life Sciences Ltd Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumย indicator, meaning the signals are instant.
  • Rangesย between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Microba Life Sciences Ltd. The current rsi is 40.60. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Microba Life Sciences Ltd Daily Relative Strength Index (RSI) ChartMicroba Life Sciences Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Comparesย a certain price to multiple prices ranging over time.

  • Leadingย momentumย indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Rangesย between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Microba Life Sciences Ltd. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Microba price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Microba Life Sciences Ltd Daily Stochastic Oscillator ChartMicroba Life Sciences Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,ย the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Microba Life Sciences Ltd. The current cci is -104.70219436.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Microba Life Sciences Ltd Daily Commodity Channel Index (CCI) ChartMicroba Life Sciences Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Microba Life Sciences Ltd. The current cmo is -22.41825301.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Microba Life Sciences Ltd Daily Chande Momentum Oscillator (CMO) ChartMicroba Life Sciences Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

ย Shows the current price relative to the highest high over the last 14 days.
ย 

  • Lagging momentum indicator
  • Ranging between 0 andย -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Microba Life Sciences Ltd. The current willr is -77.77777778.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Microba is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Microba Life Sciences Ltd Daily Williams %R ChartMicroba Life Sciences Ltd Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldย 

Score

Let's take a look at the Bollinger Bands of Microba Life Sciences Ltd.

Microba Life Sciences Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Microba Life Sciences Ltd. The current atr is 0.01313653.

Microba Life Sciences Ltd Daily Average True Range (ATR) ChartMicroba Life Sciences Ltd Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

ย Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Microba Life Sciences Ltd. The current obv is -8,195,995.

Microba Life Sciences Ltd Daily On-Balance Volume (OBV) ChartMicroba Life Sciences Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Microba Life Sciences Ltd. The current mfi is 17.30.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Microba Life Sciences Ltd Daily Money Flow Index (MFI) ChartMicroba Life Sciences Ltd Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Microba Life Sciences Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-12-30BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-12-31RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-06ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-13RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-16SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-01-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-01-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-01-23STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-01-24MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-01-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-01-29RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-01-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-03WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-05ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-02-06STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-02-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-02-13WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-02-18MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-02-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-02-20DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-02-21STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-24STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-02-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-02-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-03-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-03-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-03-05STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-03-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-13STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-17SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-03-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-03-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
2025-03-28CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-03-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-04-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-09MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-10STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-04-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-04-15STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-16MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2025-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2025-04-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-01ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-09STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-14STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-19MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-20MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-05-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

Microba Life Sciences Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Microba Life Sciences Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5040.599
Ma 20Greater thanMa 500.172
Ma 50Greater thanMa 1000.184
Ma 100Greater thanMa 2000.217
OpenGreater thanClose0.155
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Microba with someone you think should read this too:
  • Are you bullish or bearish on Microba? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Microba? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Microba Life Sciences Ltd

I send you an email if I find something interesting about Microba Life Sciences Ltd.


Comments

How you think about this?

Leave a comment

Stay informed about Microba Life Sciences Ltd.

Receive notifications about Microba Life Sciences Ltd in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.